K-Medihub (Daegu Gyeongbuk Advanced Medical Industry Promotion Foundation, Chairman Yang Jin-young) announced on the 8th that it had signed a business agreement with Okcheondang Co., Ltd. for joint research and development of a new asthma treatment based on natural products.
Okcheondang Co., Ltd. (CEO Koo Sung-min) is a manufacturer of oriental medicines and has a pipeline of new drugs made from natural products in various fields such as asthma, cancer, and Crohn's disease.
According to this agreement, the two companies will promote mutual cooperation activities for the smooth business promotion of the two organizations, including drug development and production, joint use of research facilities and equipment, research manpower, technology, information exchange, joint hosting of seminars, academic conferences, workshops, etc. decided to do
The K-Medihub Pharmaceutical Production Center will support the setting of standards and test methods and quality testing for the development of new asthma treatment.
Yang Jin-young, chairman of KMedihub, said, "Through this business agreement with Okcheondang, we will expand the scope of support beyond synthetic drugs and biopharmaceuticals to new drugs made from natural products."
